Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference

Anticipates Fourth Quarter and Full Year Results to Be Slightly Above Previously Provided Financial

Guidance

NEW YORK, January 12, 2026 (GLOBE NEWSWIRE) - Progyny, Inc. (Nasdaq: PGNY) ("Progyny" or the "Company"), a global leader in women's health and family building solutions, today announced that the Company is participating in the 44th Annual JP Morgan Healthcare Conference, where it intends to discuss its updated expectations for the quarter and year ending December 31, 2025.

"As the fourth quarter progressed, we were pleased to see that member engagement has paced favorably as compared to the guidance we issued in November," said Pete Anevski, Progyny's Chief Executive Officer. "Accordingly, we now expect our fourth quarter results for revenue, net income and Adjusted EBITDA to be slightly above the ranges that we provided in November, excluding any non-cash impacts to net income associated with the previously announced departure of Michael Sturmer as Progyny's president."

Progyny's presentation at the JP Morgan Healthcare Conference begins at 7:30 a.m. Pacific Time / 10:30 a.m. Eastern Time on Tuesday, January 13, 2026. Mr. Anevski will be joined by Mark Livingston, Chief Financial Officer, Melissa Cummings, Chief Operating Officer, and Katie Higgins, Chief Commercial Officer.

A live audiocast and replay of both the presentation and the breakout session will be available from the Events and Presentations section of Progyny's website at http://investors.progyny.com.

About Progyny

Progyny (Nasdaq: PGNY) is a global leader in women's health and family building solutions, trusted by the nation's leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive and intentionally designed solutions simultaneously benefit employers, patients, and physicians.

Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.

Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, INC. 5000, INC. Power Partners and Crain's Fast 50 for NYC. For more information, visit www.progyny.com.